A study of parenteral iron regimens in hemodialysis patients
- 31 July 1999
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 34 (1) , 21-28
- https://doi.org/10.1016/s0272-6386(99)70103-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and EpoetinNew England Journal of Medicine, 1998
- The Intensity of Hemodialysis and the Response to Erythropoietin in Patients with End-Stage Renal DiseaseNew England Journal of Medicine, 1996
- Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin eraAmerican Journal of Kidney Diseases, 1995
- Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementationAmerican Journal of Kidney Diseases, 1995
- Monitoring of iron status and iron supplementation in patients treated with erythropoietinCurrent Opinion in Nephrology and Hypertension, 1994
- Early dosing practices and effectiveness of recombinant human erythropoietinKidney International, 1993
- Effect of Serum Parathyroid Hormone and Bone Marrow Fibrosis on the Response to Erythropoietin in UremiaNew England Journal of Medicine, 1993
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- FAILURE OF SERUM FERRITIN LEVELS TO PREDICT BONE-MARROW IRON CONTENT AFTER INTRAVENOUS IRON-DEXTRAN THERAPYThe Lancet, 1982